INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Risk Mitigation For Late-Stage Clinical Assets

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

• How To Select The Right Fill-Finish CDMO For Phase I–II

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• Manufacturing Made More Robust And Customer-Centric

  12/11/2025

  Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

• Pharmaceutical Supply Chain Management Best Practices

  9/13/2024

  Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

• 5 Signs You've Outgrown Your Quality Management System (QMS)

  12/27/2024

  An outdated QMS limits growth. Explore how upgrading to an advanced, configurable system like MasterControl can ensure scalability, automation and innovation. 

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.

• The Importance Of Quality In Raw Material Selection

  1/16/2025

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization.